Short Interest in Dominari Holdings Inc. (NASDAQ:DOMH) Rises By 396.4%

Dominari Holdings Inc. (NASDAQ:DOMH) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 41,200 shares, an increase of 396.4% from the December 15th total of 8,300 shares. Based on an average daily trading volume, of 27,200 shares, the days-to-cover ratio is presently 1.5 days. Approximately 1.2% of the company’s shares are sold short.

Dominari Price Performance

Shares of DOMH stock traded down $0.05 during trading hours on Monday, hitting $1.04. The company had a trading volume of 39,688 shares, compared to its average volume of 81,185. Dominari has a fifty-two week low of $0.83 and a fifty-two week high of $3.20. The company’s fifty day moving average is $1.46 and its 200 day moving average is $1.68. The stock has a market capitalization of $6.59 million, a PE ratio of -0.27 and a beta of 1.03.

Dominari (NASDAQ:DOMH) last posted its earnings results on Friday, November 8th. The company reported ($0.45) earnings per share (EPS) for the quarter. The firm had revenue of $4.04 million for the quarter. Dominari had a negative return on equity of 32.89% and a negative net margin of 180.22%.

Dominari Company Profile

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.